Reduced risk of death at 28 days in patients taking a beta blocker before admission to hospital with myocardial infarction.

Retrospective analysis of data collected on patients admitted over four years suggests that patients taking these agents before admission to hospital with myocardial infarction have a significant survival advantage at 28 days, which may be due to a reduction in infarct size.